Supernus Pharmaceuticals, Inc. - Common Stock (NQ:SUPN)
Price and Volume
Detailed Quote| Volume | 827,302 |
| Open | 42.94 |
| Bid (Size) | 42.54 (100) |
| Ask (Size) | 42.58 (300) |
| Prev. Close | 42.81 |
| Today's Range | 42.40 - 43.29 |
| 52wk Range | 40.51 - 59.68 |
| Shares Outstanding | 53,145,884 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
28.7% below 52-week high
42.56
40.5152W Low
59.6852W High
1 Week
1.9% below 1-week high
41.131W Low
43.411W High
Supernus Pharmaceuticals, Inc. - Common Stock (SUPN) traded between $40.51 and $59.68 over the past 52 weeks and last traded at $42.56, 28.7% below its 52-week high. Over the past week it ranged between $41.13 and $43.41.
Past 12 Months
1W
-$0.27
1M
+$1.07
3M
-$4.79
6M
-$7.39
YTD
-$6.91
1Y
-$5.82
SUPN was -12.0% over the past year, -14.8% over six months, -14.0% year to date, -0.6% in the last week.
12 Months vs Market
SUPN
-12.0%
DIA
+12.2%
SPY
+17.3%
QQQ
+23.3%
IWM
+13.3%
Over the past 12 months SUPN returned -12.0% versus DIA (Dow) +12.2%, SPY (S&P 500) +17.3%, QQQ (Nasdaq 100) +23.3% and IWM (Russell 2000) +13.3%.
Volume & Liquidity
1.10× 3-mo avg
Today 827,302
3-mo avg 752.5K
1W
712.4K
1M
709.8K
3M
752.5K
6M
757.1K
YTD
744.2K
1Y
760.5K
SUPN most recently traded 827,302 shares against a 3-month average daily volume of 752.5K.
More News
Read More
2 Growth Stocks to Add to Your Roster and 1 We Question
September 28, 2026
3 Reasons SUPN is Risky and 1 Stock to Buy Instead
September 21, 2026
3 Cash-Heavy Stocks Walking a Fine Line
September 16, 2026
Supernus Pharmaceuticals to Participate in September Investor Conferences
September 02, 2026
3 Out-of-Favor Stocks We’re Skeptical Of
September 02, 2026
3 Small-Cap Stocks with Open Questions
August 25, 2026
1 Healthcare Stock with Exciting Potential and 2 We Ignore
August 18, 2026
3 Russell 2000 Stocks We Approach with Caution
August 14, 2026
Why Supernus Pharmaceuticals Stock Topped the Market Today ↗
August 03, 2026
Supernus Pharmaceuticals Q2 Earnings Call Highlights ↗
August 03, 2026
What's going on in today's pre-market session ↗
August 03, 2026
Supernus Announces Second Quarter 2026 Financial Results
August 03, 2026
Frequently Asked Questions
Is Supernus Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Supernus Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Supernus Pharmaceuticals, Inc. - Common Stock trade on?
Supernus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock is SUPN on the Nasdaq Stock Market
What is the current price of Supernus Pharmaceuticals, Inc. - Common Stock?
The current price of Supernus Pharmaceuticals, Inc. - Common Stock is 42.56
When was Supernus Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Supernus Pharmaceuticals, Inc. - Common Stock was at 10/13/26 02:42 PM ET
What is the market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock is 2.26B
How many shares of Supernus Pharmaceuticals, Inc. - Common Stock are outstanding?
Supernus Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.